title: [Risk prevention in patients on antithrombotic therapy for common oral invasive treatment].
abstract: The high incidence of cardiovascular diseases makes the dentists have more chance to treat patients who receive antithrombotic therapy. Limited by the profession, many dentists are unfamiliar with the systemic disease that the patients suffer from, especially struggle with whether or not to stop the antithrombotic therapy before the invasive diagnosis and treatment such as tooth extraction, dental implant placement and periodontal treatment. Stopping antithrombotic drugs may lead to thrombosis risk, while sustaining antithrombotic drug treatment may lead to bleeding risk. Through literature review and the experience of oral diagnosis and treatment of patients with cardiovascular diseases in our department for many years, the author aims to discuss preventive measures of bleeding and thrombosis risk of patients with oral antithrombotic therapy in oral invasive diagnosis.
authors.affiliation: Medical Center of Stomatology, Beijing An Zhen Hospital, Capital Medical University, Beijing 100029, China.
authors.forename: Y L
authors.initials: YL
authors.lastname: Lyu
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003757:Dental Implantation / Q000009:adverse effects; D003813:Dentistry; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010510:Periodontal Diseases / Q000175:diagnosis / Q000628:therapy; D011322:Primary Prevention; D012306:Risk; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014081:Tooth Extraction / Q000009:adverse effects
chemical_list: D005343:Fibrinolytic Agents